Rivastigmine Tartrate

Basic Information

Product Name

FDA Product Code

46708-063

Regulatory Information

NDC Product Code

46708-063

Application Number

ANDA091689

Marketing Category

C73584

Effective Date

January 16, 2023

Territorial Authority

USA

FDA Title

These highlights do not include all the information needed to use Rivastigmine Tartrate Capsules USP safely and effectively. See full prescribing information for Rivastigmine Tartrate Capsules USP. Rivastigmine Tartrate Capsules USP, for oral use. Initial U.S. Approval: 2000

Labeling Type

Human Prescription Drug Label

Version Number

Active Ingredients

HYPROMELLOSE, UNSPECIFIED

Code: 3NXW29V3WO

Class Code: IACT

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

MICROCRYSTALLINE CELLULOSE

Code: OP1R32D61U

Class Code: IACT

SILICON DIOXIDE

Code: ETJ7Z6XBU4

Class Code: IACT

GELATIN, UNSPECIFIED

Code: 2G86QN327L

Class Code: IACT

RIVASTIGMINE TARTRATE

Quantity: 1.5 mg in 1 1

Code: 9IY2357JPE

Class Code: ACTIM

TITANIUM DIOXIDE

Code: 15FIX9V2JP

Class Code: IACT

FERRIC OXIDE YELLOW

Code: EX438O2MRT

Class Code: IACT

Active Moieties

RIVASTIGMINE

Code: PKI06M3IW0

Basic Information

Regulatory Information

Company Information

Active Ingredients

HYPROMELLOSE, UNSPECIFIED

MAGNESIUM STEARATE

MICROCRYSTALLINE CELLULOSE

SILICON DIOXIDE

GELATIN, UNSPECIFIED

TITANIUM DIOXIDE

FERRIC OXIDE YELLOW

Active Moieties

RIVASTIGMINE